RARE CANCERS
Clinical trials for RARE CANCERS explained in plain language.
Never miss a new study
Get alerted when new RARE CANCERS trials appear
Sign up with your email to follow new studies for RARE CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer patients on targeted therapy get extended safety monitoring
Disease control Recruiting nowThis study provides continued access to dabrafenib and/or trametinib for up to 100 patients with melanoma, lung cancer, or other solid tumors who were benefiting from these drugs in a prior Novartis or GSK trial. The main goal is to track long-term side effects and safety over ti…
Matched conditions: RARE CANCERS
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Rare cancer hope: genetic tests may match patients to better treatments
Knowledge-focused Recruiting nowThis study is testing whether genetic testing of tumors and blood can help doctors choose better treatments for people with rare cancers. About 400 adults with rare solid tumors or lymphomas will have their tumors genetically analyzed. A team of experts will review the results an…
Matched conditions: RARE CANCERS
Phase: NA • Sponsor: TargetCancer Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC